Big news: our prices just got a lot lower. Shop now|New here? Get up to $200 in welcome perks, valid for 14 days. Claim offer now
US shipping INCLUDED on orders above $200
Research Insights

All content and product details on this site are for educational purposes only. Products are for in-vitro studies (performed outside the body) and not FDA-approved for medical use. Any introduction into humans or animals is prohibited by law.

Epithalon Peptide Research: Telomerase Biology, Chromatin Remodeling, and Pineal Gland Studies

Nabiha Khalid
October 27, 2026
Epithalon Peptide Research: Telomerase Biology, Chromatin Remodeling, and Pineal Gland Studies

Brief Overview/Summary

This article surveys published laboratory research on the synthetic tetrapeptide Epithalon (AEDG), examining its studied interactions with telomerase enzyme activity, chromatin structure, pineal gland signaling, and melatonin biosynthesis pathways.

The tetrapeptide known as Epithalon, also spelled "Epitalon," carries the amino acid sequence Ala-Glu-Asp-Gly (AEDG) [1]. Epithalon is a synthetic peptide constructed on the basis of the amino acid composition of epithalamin, a polypeptide extract derived from bovine pineal glands, and AEDG was later detected among the tetrapeptides of the pineal polypeptide complex [1][2]. In preclinical research, it has been studied as a telomerase-activating agent and a bioregulatory peptide influencing gene expression [3][4]. The majority of published research on Epithalon and Epithalamin has been conducted in Russia by the St. Petersburg Institute of Bioregulation and Gerontology and collaborating institutes, principally under the direction of Vladimir Khavinson [5].

Mechanism of Action of Epithalon Peptide

Epithalon, with the amino acid sequence Ala-Glu-Asp-Gly, is a synthetic peptide that has been reported to induce the activation of ribosomal genes, the decondensation of pericentromeric structural heterochromatin, and the release of genes repressed through age-associated condensation of euchromatic chromosome regions in cultured lymphocytes from older donors [6]. In cell cultures, it has been associated with induction of telomerase activity and telomere elongation [3][7]. Molecular modelling suggests that it binds to H1 histone subtypes, which has been proposed as one epigenetic mechanism for its effects on gene expression [4]. As with other bioregulatory peptides, proposed mechanisms involve modulation of gene expression and protein synthesis [4][1].

Research Evidence of Epithalon Peptide

In both in vitro and in vivo settings, the developmental potential of oocytes declines with time after ovulation. Epitalon has been described as an antioxidant comparable to melatonin, and one study investigated whether it protects post-ovulatory mouse oocytes in culture: it reduced intracellular reactive oxygen species, the frequency of spindle defects and abnormal cortical-granule distribution, and decreased apoptosis of the oocytes [8].

Epithalon has also been examined for its effects on spontaneous tumor incidence in inbred CBA mice, HER-2/neu transgenic mice and Swiss-derived SHR mice, and on chemically-induced colon tumor development in rat models [9][10][11][12].

In transgenic FVB/N HER-2/neu mouse models, researchers reported a 34.2% increase in the mean lifespan of neoplasm-free animals exposed to Epithalon, a 1.6-fold reduction in lung metastases and a twofold reduction in multiple tumors; the number of tumor-free mice was increased 3.7-fold, and the lifespan of tumor-bearing mice was approximately 1.4 times longer than in controls [10]. Epithalon exposure was also associated with slowed development of age-related reproductive changes [10]. A separate study in the same model reported a smaller cumulative number and size of mammary tumors and a 3.7-fold reduction in HER-2/neu mRNA expression in the tumors [13].

In outbred Swiss-derived SHR mice, Epitalon did not change mean lifespan, but the lifespan of the last 10% of survivors was 13.3% longer and the maximum lifespan 12.3% longer than in controls. Epitalon did not significantly affect overall spontaneous tumor incidence; however, it was associated with a sixfold reduction in leukemia development relative to controls [11].

In female CBA mice, the pineal tetrapeptide was associated with a 5.3% longer mean survival, slower age-related decline of estrous function and lower spontaneous tumor incidence, mainly lung adenomas [9].

In a rat tumor model using 1,2-dimethylhydrazine-induced carcinogenesis, Epithalon administration was associated with fewer colon tumors per animal and with inhibited tumor development in the jejunum and ileum of LIO rats [12].

In the same model, Epithalon was associated with reduced mitotic activity in tumor cells, with a concurrently high level of apoptosis, when exposure continued throughout the experiment [14].

In senescence-accelerated SAMP-1 mice, Melatonin or Epithalon administration was associated with longer mean and maximum survival in the last 10% of survivors [15].

Research Applications of Epithalon Peptide

Research on the pineal gland has examined Epithalon's relationship with melatonin. In senescent rhesus monkeys, Epithalon was reported to stimulate evening melatonin synthesis and to normalise the circadian rhythm of cortisol secretion [16].

In contrast, in perifused pineal glands from young and old rats, the AEDG tetrapeptide had no significant effect on melatonin secretion, either alone or after stimulation with isoproterenol [17].

The pineal polypeptide complex and AEDG have been reported to exert similar biological effects, and AEDG has been proposed as the component responsible for the effects of the complex [2]. The reasons for the differences between species in melatonin findings have not been established.

Preclinical studies in Drosophila, murine, and rat models have reported increases in survival measures in exposed cohorts compared to controls [18][11][9]. In Drosophila, Epitalon added to the culture medium during development increased the lifespan of adult flies by 11–16% [18].

In human fetal fibroblast models, Epithalon exposure was associated with telomere elongation and with about ten additional cell divisions beyond the point at which control cells stopped dividing, a finding the authors described as overcoming the Hayflick replicative limit [3][19]. Cultured lymphocytes from donors aged 76–80 years exposed to Epithalon exhibited chromatin remodeling events, suggesting possible epigenetic mechanisms [6]. These findings originate primarily from Dr. Khavinson's laboratory; a 2025 study from an independent group reported telomere elongation in normal human epithelial and fibroblast cells through hTERT and telomerase upregulation, and through alternative lengthening of telomeres in breast cancer cell lines [7].

In human gingival mesenchymal stem cells, AEDG increased the synthesis and mRNA expression of the neurogenic differentiation markers Nestin, GAP43, β-tubulin III and doublecortin [4]. In rats, Epithalon has also been examined for its effects on the activity of gastrointestinal enzymes in young and older animals [20].

Epithalon has also been examined in the context of cancer biology research. Based on several preclinical investigations in cancer-prone murine and rat models, Epithalon administration was associated with reduced rates of tumor formation [10][11][12].

  • Safety: The available data come from cell-culture and animal studies and do not establish the safety of Epithalon in any species. Epithalamin is a polypeptide complex containing free amino acids and many di-, tri- and tetrapeptides [2], so findings for the extract and for synthetic Epithalon are not interchangeable; for synthetically produced Epithalon, impurity profiles represent an important variable that requires characterization.

  • Regulatory status: Epithalon supplied by Power Peptides is intended for laboratory research use only. Study protocols in the literature reviewed here varied; see the cited publications.

Future Research Perspectives of Epithalon Peptide

Epithalon's studied capacity to influence telomerase activity positions it as a subject of ongoing interest in cellular research contexts examining telomerase regulation and oxidative stress response pathways [3][7][8].

Investigations have explored its potential implications for chromatin remodeling and gene expression, stemming from its observed effects on heterochromatin and its proposed binding to histones in laboratory models [6][4].

Its interactions with pineal function, melatonin secretion and circadian hormone rhythms represent active areas of inquiry in neuroendocrine research contexts [16][17].

Its proposed role in oxidative stress response further expands its mechanistic research interest [8][1].

While independent findings remain limited, the properties of bioregulatory peptides such as Epithalon continue to inform broader investigations into cellular regulatory mechanisms and replicative biology [1][7].

References

  1. Araj SK, Brzezik J, Mądra-Gackowska K, Szeleszczuk Ł. Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties. Int J Mol Sci. 2025;26(6):2691. doi: 10.3390/ijms26062691. PMID: 40141333.

  2. Khavinson VK, Kopylov AT, Vaskovsky BV, Ryzhak GA, Lin'kova NS. Identification of Peptide AEDG in the Polypeptide Complex of the Pineal Gland. Bull Exp Biol Med. 2017;164(1):41-43. doi: 10.1007/s10517-017-3922-8. PMID: 29124531.

  3. Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590-592. doi: 10.1023/a:1025493705728. PMID: 12937682.

  4. Khavinson V, Diomede F, Mironova E, Linkova N, Trofimova S, Trubiani O, Caputi S, Sinjari B. AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism. Molecules. 2020;25(3):609. doi: 10.3390/molecules25030609. PMID: 32019204.

  5. Anisimov VN, Khavinson VKh. Peptide bioregulation of aging: results and prospects. Biogerontology. 2010;11(2):139-149. doi: 10.1007/s10522-009-9249-8. PMID: 19830585.

  6. Khavinson VKh, Lezhava TA, Monaselidze JR, Jokhadze TA, Dvalishvili NA, Bablishvili NK, Trofimova SV. Peptide Epitalon activates chromatin at the old age. Neuro Endocrinol Lett. 2003;24(5):329-333. PMID: 14647006.

  7. Al-Dulaimi S, Thomas R, Matta S, Roberts T. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology. 2025;26(5):178. doi: 10.1007/s10522-025-10315-x. PMID: 40908429.

  8. Yue X, Liu SL, Guo JN, Meng TG, Zhang XR, Li HX, Song CY, Wang ZB, Schatten H, Sun QY, Guo XP. Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro. Aging (Albany NY). 2022 Apr 12;14(7):3191-3202. doi: 10.18632/aging.204007. PMID: 35413689; PMCID: PMC9037278.

  9. Anisimov VN, Khavinson VK, Mikhalski AI, Yashin AI. Effect of synthetic thymic and pineal peptides on biomarkers of ageing, survival and spontaneous tumour incidence in female CBA mice. Mech Ageing Dev. 2001;122(1):41-68. doi: 10.1016/s0047-6374(00)00184-6. PMID: 11163623.

  10. Anisimov VN, Khavinson VKh, Alimova IN, Semchenko AV, Yashin AI. Epithalon decelerates aging and suppresses development of breast adenocarcinomas in transgenic her-2/neu mice. Bull Exp Biol Med. 2002;134(2):187-190. doi: 10.1023/a:1021104819170. PMID: 12459848.

  11. Anisimov VN, Khavinson VKh, Popovich IG, Zabezhinski MA, Alimova IN, Rosenfeld SV, Zavarzina NY, Semenchenko AV, Yashin AI. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003;4(4):193-202. doi: 10.1023/a:1025114230714. PMID: 14501183.

  12. Anisimov VN, Khavinson VKh, Popovich IG, Zabezhinski MA. Inhibitory effect of peptide Epitalon on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats. Cancer Lett. 2002;183(1):1-8. doi: 10.1016/s0304-3835(02)00090-3. PMID: 12049808.

  13. Anisimov VN, Khavinson VK, Provinciali M, Alimova IN, Baturin DA, Popovich IG, Zabezhinski MA, Imyanitov EN, Mancini R, Franceschi C. Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Int J Cancer. 2002;101(1):7-10. doi: 10.1002/ijc.10570. PMID: 12209581.

  14. Kossoy G, Zandbank J, Tendler E, Anisimov V, Khavinson V, Popovich I, Zabezhinski M, Zusman I, Ben-Hur H. Epitalon and colon carcinogenesis in rats: proliferative activity and apoptosis in colon tumors and mucosa. Int J Mol Med. 2003;12(4):473-477. doi: 10.3892/ijmm.12.4.473. PMID: 12964022.

  15. Anisimov VN, Popovich IG, Zabezhinskiĭ MA, Rozenfel'd SV, Khavinson VKh, Semenchenko AV, Iashin AI. Effect of epitalon and melatonin on life span and spontaneous carcinogenesis in senescence accelerated mice (SAM). Vopr Onkol. 2005;51(1):93-98. (In Russian, English abstract.) PMID: 15909815.

  16. Khavinson V, Goncharova N, Lapin B. Synthetic tetrapeptide epitalon restores disturbed neuroendocrine regulation in senescent monkeys. Neuro Endocrinol Lett. 2001;22(4):251-254. PMID: 11524632.

  17. Djeridane Y, Khavinson VKh, Anisimov VN, Touitou Y. Effect of a synthetic pineal tetrapeptide (Ala-Glu-Asp-GLy) on melatonin secretion by the pineal gland of young and old rats. J Endocrinol Invest. 2003;26(3):211-215. doi: 10.1007/BF03345159. PMID: 12809170.

  18. Khavinson VK, Izmaylov DM, Obukhova LK, Malinin VV. Effect of epitalon on the lifespan increase in Drosophila melanogaster. Mech Ageing Dev. 2000;120(1-3):141-149. doi: 10.1016/s0047-6374(00)00217-7. PMID: 11087911.

  19. Khavinson VKh, Bondarev IE, Butyugov AA, Smirnova TD. Peptide promotes overcoming of the division limit in human somatic cell. Bull Exp Biol Med. 2004;137(5):503-506. doi: 10.1023/b:bebm.0000038164.49947.8c. PMID: 15455129.

  20. Khavinson VKh, Malinin VV, Timofeeva NM, Egorova VV, Nikitina AA. Effects of epithalon on activities gastrointestinal enzymes in young and old rats. Bull Exp Biol Med. 2002;133(3):290-292. doi: 10.1023/a:1015807305791. PMID: 12360355.

Read more about peptides